Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-16-000084

CEO bought 7,000 shares at $0.14 ($952)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-07-18 Purchase : show line 1 in the form +7,000 $0.14 $952 7,100,619 D
Open-market purchases · 7,000 sh · avg $0.14 · $952
Loading xslF345X03/primary_doc.xml…